Barry Flannelly
Director/Board Member at PROTARA THERAPEUTICS, INC.
Net worth: 4 M $ as of 31/05/2024
Barry Flannelly active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 01/08/2014 | - |
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 23/07/2020 | - |
| Independent Dir/Board Member | 23/07/2020 | - |
Career history of Barry Flannelly
Former positions of Barry Flannelly
| Companies | Position | Start | End |
|---|---|---|---|
| GENOMIC HEALTH, INC. | Director/Board Member | 16/04/2019 | 08/11/2019 |
| OSS Healthcare, Inc. | Chief Executive Officer | 01/08/2013 | 01/07/2014 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/04/2011 | 01/04/2013 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/08/2008 | 01/01/2011 |
| Johns Hopkins Oncology Center | Corporate Officer/Principal | - | - |
Training of Barry Flannelly
| University of Maryland School of Pharmacy | Doctorate Degree |
| University of Baltimore | Masters Business Admin |
| Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
Statistics
International
| United States | 11 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
| OSS Healthcare, Inc. | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
| Johns Hopkins Oncology Center |
- Stock Market
- Insiders
- Barry Flannelly
- Experience
